Indiplon-MR: NBIX started the double-blind, placebo-controlled international Phase III SLEEP trial in 600 patients. Secondary endpoints include sleep quality, n

Neurocrine Biosciences Inc. (NBIX), San Diego, Calif.
Product: Indiplon-MR

Read the full 94 word article

How to gain access

Continue reading with a
two-week free trial.